MARKET

BNGO

BNGO

Bionano Genomics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.09
-0.10
-1.62%
After Hours: 6.05 -0.04 -0.66% 19:58 07/29 EDT
OPEN
6.22
PREV CLOSE
6.19
HIGH
6.33
LOW
5.99
VOLUME
6.72M
TURNOVER
--
52 WEEK HIGH
15.69
52 WEEK LOW
0.4735
MARKET CAP
1.70B
P/E (TTM)
-21.5652
1D
5D
1M
3M
1Y
5Y
Bionano (BNGO) to Report Q2 Earnings: What's in the Cards?
Bionano Genomics (BNGO) is likely to provide updates on earnings and revenues when it reports second-quarter 2021 results.
Zacks · 13h ago
Bionano Genomics to Report Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 4, 2021
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 4, 2021 at 4:30 p.m. Eastern Time to report financial results for the second quarte...
GlobeNewswire · 1d ago
Bionano Genomics Reports Number Of Presentations On Optical Genome Mapping Between Aug. 1-4
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a record number of optical genome mapping (OGM) presentations scheduled to appear at the annual Cancer Genomics Consortium (CGC) meeting being held from August 1 - 4,
Benzinga · 2d ago
Bionano Genomics Announces a Record Number of Optical Genome Mapping Presentations Scheduled to Appear at the Annual Cancer Genomics Consortium Meeting from August 1st - 4th, 2021
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a record number of optical genome mapping (OGM) presentations scheduled to appear at the annual Cancer Genomics Consortium (CGC) meeting being held from Augu...
GlobeNewswire · 2d ago
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $5.87, marking a -1.68% move from the previous day.
Zacks · 3d ago
AMC Entertainment Tops Q2 Trends For Millenials And Gen Z, WISH Enters The Top 100
A quarterly report from Apex Clearing shows what the top owned stocks are among Millenials and Gen Z. Here is a look at the top holdings and the biggest movers from the first quarter.
Benzinga · 3d ago
Bionano down 6% premarket despite results from genomic mapping systems
CIPhotos/iStock via Getty Images Bionano Genomics ("BNGO") shares are down 6% in premarket trading despite releasing data showing its Saphyr system for optical genomic mapping was able achieve a whole
Seekingalpha · 07/19 12:53
Bionano Genomics Highlights Co's Optical Genome Mapping For Acute Lymphoblastic Leukemia
Bionano Genomics, Inc. (NASDAQ:BNGO) announces a summary of the results obtained by the University Hospitals Leuven, Belgium with optical genome mapping (OGM) with Bionano's Saphyr® system. An assay was
Benzinga · 07/19 12:06
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BNGO. Analyze the recent business situations of Bionano Genomics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BNGO stock price target is 11.50 with a high estimate of 14.00 and a low estimate of 10.00.
EPS
Institutional Holdings
Institutions: 122
Institutional Holdings: 43.22M
% Owned: 15.50%
Shares Outstanding: 278.85M
TypeInstitutionsShares
Increased
28
12.17M
New
82
19.98M
Decreased
5
1.12M
Sold Out
12
318.57K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.96%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Non-Executive Chairman/Independent Director
David Barker
President/Chief Executive Officer/Director
R. Erik Holmlin
Chief Financial Officer
Christopher Stewart
Chief Operating Officer
Mark Oldakowski
Other
Alka Chaubey
Other
Jason Priar
Independent Director
Yvonne Linney
Independent Director
Albert Luderer
Independent Director
Hannah Mamuszka
Independent Director
Christopher Twomey
Independent Director
Kristiina Vuori
No Data
  • All
  • Financials
  • Insiders
More
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response. The Company’s subsidiary, Lineagen, Inc., provides molecular diagnostics services for individuals.

Webull offers kinds of BioNano Genomics Inc stock information, including NASDAQ:BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNGO stock methods without spending real money on the virtual paper trading platform.